iTeos Therapeutics ITOS

$ 8.84 0.34%

Quarterly report 2024-Q2
added 08-08-2024

iTeos Therapeutics Financial Statements 2011-2024 | ITOS

Annual Financial Statements iTeos Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	421 M	555 M	1.64 B	779 M	-	-	-	-	-	-	-	-	-
Shares	35.8 M	35.6 M	35.2 M	24.3 M	-	-	-	-	-	-	-	-	-
Historical Prices	11.8	15.6	46.6	33.8	-	-	-	-	-	-	-	-	-
Net Income	-113 M	96.7 M	215 M	-38 M	-22.5 M	-18.1 M	-	-	-	-	-	-	-
Revenue	12.6 M	268 M	345 M	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-151 M	126 M	245 M	-45.2 M	-28 M	-	-	-	-	-	-	-	-
Interest Expense	4.08 M	7.79 M	1.3 M	-48 K	-85 K	-	-	-	-	-	-	-	-
EBITDA	-150 M	127 M	246 M	-38.8 M	-22.7 M	-17.3 M	-	-	-	-	-	-	-
Operating Expenses	164 M	141 M	99.9 M	39.3 M	23.3 M	17.8 M	-	-	-	-	-	-	-
General and Administrative Expenses	50.4 M	43.9 M	40.5 M	15.3 M	8.84 M	4.31 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement iTeos Therapeutics

	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	39.7 M	35.8 M	35.8 M	35.8 M	35.7 M	35.6 M	35.6 M	35.5 M	35.5 M	35.5 M	35.2 M	35.1 M	35.1 M	35 M	24.3 M	349 K	257 K	257 K	186 K	186 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-7.13 M	-	-32.2 M	-34.3 M	-15.6 M	-	991 K	5.63 M	69.6 M	-	69.6 M	-26.5 M	-13.5 M	-	-10.7 M	-7.2 M	-5.25 M	-	-6.92 M	-5.76 M	-4.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	35 M	-	-	-	12.6 M	-	19.5 M	41.7 M	153 M	-	104 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-14.2 M	-	-43.3 M	-42.6 M	-24.9 M	-	-15.2 M	3.34 M	121 M	-	79.4 M	-29.3 M	-18.7 M	-	-13.5 M	-8.53 M	-8.24 M	-	-7.7 M	-6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	67 K	-	771 K	326 K	1.65 M	-	9.28 M	3.61 M	-2.12 M	-	-8.48 M	60 K	240 K	-	265 K	12 K	-42 K	-	-2 K	-47 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-13.9 M	-	-43.1 M	-42.4 M	-24.7 M	-	-15 M	3.54 M	121 M	-	79.6 M	-29.1 M	-18.6 M	-	-13.4 M	-8.43 M	-8.12 M	-	-7.23 M	-5.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	49.2 M	-	43.3 M	42.6 M	37.5 M	-	34.7 M	38.4 M	31.7 M	-	24.9 M	29.3 M	18.7 M	-	13.5 M	8.53 M	8.24 M	-	7.7 M	6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	12.5 M	-	12.6 M	13.4 M	11.9 M	-	10.8 M	11.5 M	10.6 M	-	8.76 M	15.1 M	7.05 M	-	4.8 M	2.39 M	2.42 M	-	2.7 M	2.09 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency